Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 18, Issue 4, Pages 557-564
Publisher
Oxford University Press (OUP)
Online
2015-10-09
DOI
10.1093/neuonc/nov245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs
- (2014) P. P. Patwardhan et al. CLINICAL CANCER RESEARCH
- Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
- (2014) A. Omuro et al. CLINICAL CANCER RESEARCH
- Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain
- (2014) Monica R.P. Elmore et al. NEURON
- PDGFRAAmplification is Common in Pediatric and Adult High-Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma
- (2013) Joanna J. Phillips et al. BRAIN PATHOLOGY
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
- (2013) Krishna P.L. Bhat et al. CANCER CELL
- Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response
- (2013) Malgorzata Sielska et al. JOURNAL OF PATHOLOGY
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- A Roundtable Discussion on the Clinical Challenges and Options for the Treatment of Glioblastoma: Introducing a Novel Modality, TTFields
- (2013) Nicholas Butowski et al. SEMINARS IN ONCOLOGY
- Genomic Estimates of Aneuploid Content in Glioblastoma Multiforme and Improved Classification
- (2012) B. Li et al. CLINICAL CANCER RESEARCH
- Unknown
- (2012) Salvatore Coniglio et al. MOLECULAR MEDICINE
- Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
- (2012) Jane R. Engler et al. PLoS One
- Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
- (2011) J. L. Clarke et al. NEURO-ONCOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymorphism in the Microglial Cell-MobilizingCX3CR1Gene Is Associated With Survival in Patients With Glioblastoma
- (2008) Mathieu Rodero et al. JOURNAL OF CLINICAL ONCOLOGY
- Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
- (2008) Y Komohara et al. JOURNAL OF PATHOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search